drugset / Trial / NCT05119101

Dexamedtomidine in Control of Intracranial Pressure in Preeclampsia

NCT05119101

Phase 1 Unknown 100 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The present study is designed to evaluate the differences in the effect of Mg sulphate alone and dexmedetomidine as an adjuvant to Mg sulphate on intracranial pressure when administered intravenously in cases of pre-eclampsia

Timeline

Start
2022-03-01
Primary completion
2023-10
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.15 ug/kg Intravenous
Comparator Magnesium Sulfate Other / unclassified 1 g Intravenous

Indications